Showing 8281-8290 of 20875 results for "".
Difficulty with Diabetes: Strategies to Overcome Challenging Cases
https://reachmd.com/programs/diabetes-discourse/difficulty-with-diabetes-strategies-to-overcome-challenging-cases/12060/What are some strategies endocrinologists can use to better manage challenging cases?How Your Words Will (or Won't) Instill Confidence in Your Patients
https://reachmd.com/programs/speaking-of/how-your-words-will-or-wont-instill-confidence-your-patients/7925/Imagine if you are a patient about to receive some difficult news. The doctor walks in and says "I think this is a temporary setback” or "I believe you’ll be okay.” How would you react to news presented in this way, and would you have confidence in your doctor's ability to see you through the healthHow Will Pharmacogenomics Play a Role in Diabetes Therapy?
https://reachmd.com/programs/diabetes-discourse/how-will-pharmacogenomics-play-a-role-in-diabetes-therapy/4879/Pharmacogenomics is applied to select medications with the goal of optimizing drug therapy: maximizing efficacy, minimizing toxicity, and minimizing pharmacokinetic and pharmacodynamic variability. Join guest host, Dr. Candis Morello and Dr. Joseph Ma, assistant professor of clinical pharmacy at theKeeping an Eye on Macular Degeneration
https://reachmd.com/programs/revealing-retina/keeping-an-eye-on-macular-degeneration/2158/Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. They will discuss the different types of macular degeneration, the demographics involved and who should be treating iGlycemic Control and Macrovascular Outcomes in Patients with Diabetes Using the Archimedes Model
https://reachmd.com/programs/diabetes-discourse/glycemic-control-and-macrovascular-outcomes-in-patients-with-diabetes-using-the-archimedes-model/5906/The assessment of intensive glycemic control in preventing cardiovascular disease is unclear. Discrepancies in recent clinical trials such as ACCORD, ADVANCE, PROactive and UKPDS 80 may reflect difference in study design and patients, versus glycemic control. How can using the Archimedes model illumA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/a-case-of-missed-diagnosis-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37713/Examine a case of misdiagnosed proliferative diabetic retinopathy, highlighting risk factors, imaging findings, and referral timing.A Multi-Pillar Approach to Cardio-Renal Risk Reduction
https://reachmd.com/programs/heart-matters/multi-pillar-approach-cardio-renal-risk-reduction/54801/Even when traditional treatment targets are met, patients with chronic kidney disease (CKD) and type 2 diabetes remain at elevated cardiovascular and renal risk. However, emerging evidence suggests that addressing multiple disease pathways simultaneously may help reduce residual risk and improve lonThe Role of PARP Inhibitors in Metastatic Breast Cancer
https://reachmd.com/programs/project-oncology/the-role-of-parp-inhibitors-in-metastatic-breast-cancer/15820/PARP inhibitors are a type of targeted therapy used in the treatment of MBC by blocking the activity of an enzyme. Read more.Insulin Pumps
https://reachmd.com/programs/clinicians-roundtable/insulin-pumps/1919/Insulin pumps have helped to revolutionize diabetes management. What do you and your patients need to know about these pumps? Host Dr. Leslie Lundt welcomes certified diabetes educator Sue Isawa to discuss the ins and outs of insulin pumps.Top Communication Strategies from an OB-GYN Practice
https://reachmd.com/programs/advances-in-womens-health/top-communication-strategies-from-an-ob-gyn-practice/12716/How can we counsel our patients and navigate the “I want, I need” mantra we might hear from them?